Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 13, 2011
Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performanceM I Evans, D A Krantz, T W Hallahan, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 16, 2014
Cell-free fetal DNA screening in the USA: a cost analysis of screening strategiesM I Evans, J D Sonek, T W Hallahan, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|May 12, 2007
Genetic sonography after first-trimester Down syndrome screeningD A Krantz, T W Hallahan, V J Macri, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|February 26, 1998
First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucencyF Orlandi, G Damiani, T W Hallahan, et al.
Obstetrics and Gynecology|July 26, 2000
First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucencyD A Krantz, T W Hallahan, F Orlandi, et al.
Prenatal Diagnosis|October 30, 1998
Comparison of urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalitiesT W Hallahan, D A Krantz, L Tului, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Dual site model for the organogenic activity of angiogeninT W Hallahan, R Shapiro, B L Vallee
Biochemistry|September 1, 1992
Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogeninT W Hallahan, R Shapiro, D J Strydom, et al.
Pageof 3